688553.SHG Sichuan Huiyu Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
11.40 CNY
Close of Nov 5, 2026
9.61 17.02
Market cap
CNY 7.14B
P/E
54.3x
P/B
1.78x
ROE
3.1%
Dividend yield
2.79%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688553.SHG undervalued?

Graham number
Price11.40
Graham value5.50
Premium107.2%

688553.SHG trades 107.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sichuan Huiyu Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Sichuan Huiyu Pharmaceutical Co Ltd yet.

Sichuan Huiyu Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sichuan Huiyu Pharmaceutical Co Ltd

Sichuan Huiyu Pharmaceutical Co., Ltd. researches, develops, produces, and sells anti-tumor injection in China and internationally. It offers injection drug products, such as pemetrexed disodium, methrotrexate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, amifostine, levofolate calcium, thiotepa, fulvestrant, and…

Full company profile